Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-24-008520

Director sold 26,209 shares at an average $373.22 ($9,781,715)

  • Director acquired 15,000 shares (option exercise)
  • Director gave 1,851 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

SULLIVAN LOUIS W · Director

Table I: Non-derivative

26 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-18 Exercise or conversion : show line 1 in the form +15,000 $175.43 $2,631,450 31,260 D
2024-12-18 Sale : show line 2 in the form −1,121 $366.11 $410,407 30,139 D
2024-12-18 Sale : show line 3 in the form −600 $366.97 $220,184 29,539 D
2024-12-18 Sale : show line 4 in the form −1,307 $368.50 $481,632 28,232 D
2024-12-18 Sale : show line 5 in the form −2,100 $369.32 $775,563 26,132 D
2024-12-18 Sale : show line 6 in the form −1,400 $370.30 $518,413 24,732 D
2024-12-18 Sale : show line 7 in the form −1,501 $373.12 $560,048 23,231 D
2024-12-18 Sale : show line 8 in the form −200 $371.25 $74,249 23,031 D
Open-market sales · 26,209 sh · avg $373.22 · $9,781,715

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-12-18 Exercise or conversion : show line 27 in the form Stock Options −15,000 $175.43 2025-06-26 15,000 0 D
Loading xslF345X05/primarydocument.xml…